ALIGN TECHNOLOGY INC
Nasdaq: ALGN·Tempe, Arizona·CIK 0001097149
- Price
- $165.98
- Base IV
- $76.29
Valuation snapshot
At $165.98, the price is above even our bull case of $111.57.
Values per share, from an .
- No growth
- …
- Loading earnings power
- Base case
- $76.29
- 46% of the price · range $49.13–$111.57
- Price vs base case
- 118% above
- $165.98 against $76.29
- Base case · our researched forecast, 2026-11-13See the research ↗
- Price vs base · derived: price − base caseWhat the price expects ↗
- Price · StockValuer price feed, 2026-11-16 closeno link today
Whisker on the base case runs bear $49.13 to bull $111.57. Values per share.
Price against each value
- Bear case
- $49.13
- Price 238% above
- No growth
- …
- —
- Base case
- $76.29
- Price 118% above
What does Align Technology do?
Align Technology provides orthodontists and dental laboratories with clear aligners, intraoral scanners, and CAD/CAM software to treat tooth misalignment and manage digital dental workflows.
It brought in $4.2B of sales in the 12 months to Sep 2026.
Led by Joseph M. Hogan, President and Chief Executive Officer since 2015. Align Technology Form 8-K, Item 5.02
- Industry
- Healthcare
- Based in
- Tempe, Arizona
- Trades on
- Nasdaq as ALGN
Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 12¢ was left as profit after every cost, interest and tax. The biggest cost is sales, marketing and admin, 43¢ of every dollar.
- Making what it sells31¢
- Research and development9¢
- Sales, marketing and admin43¢
- Everything else it takes to operate2¢
- Tax4¢
- Left as profit12¢
- Interest and other income came back in+1¢
Who pays Align Technology, and for what?
Align makes custom Invisalign clear aligners and retainers, iTero dental scanners, and exocad software for dental practices and labs. It earns most of its revenue from clear aligner products and the rest from scanner systems, related services, and dental design software.
Its direct customers are mainly orthodontists, general dentists, dental laboratories, and dental support organizations, which provide treatment or related services to patients.
Clear Aligner
80%Invisalign treatment packages and related products, including retainers, training, and accessories.
Invisalign clear alignersImage: Align Technology Systems and Services
20%iTero scanners and related sales and services, plus exocad dental design software.
Where its work physically happens, beyond headquarters:
- Juarez manufacturing facility — Juarez, Mexico. The facility fabricates clear aligners and performs final assembly and certain repairs for iTero scanners.
- Wroclaw manufacturing facility — Wroclaw, Poland. This regional clear aligner fabrication facility serves customers closer to European markets and adds production capacity.
- Ziyang manufacturing facility — Ziyang, China. The facility fabricates clear aligners and produces, assembles, and repairs iTero scanners for Align’s regional operations.
- Petah Tikva scanner facility — Petah Tikva, Israel. This manufacturing and R&D facility produces scanner wands and performs final assembly and repairs for iTero scanners.
- Belen treatment planning facility — Belen, Costa Rica. The facility houses treatment planning personnel and customer care that support Align’s customized clear aligner workflow.
How is the business doing?
Sales grew from $2.5B in 2020 to $4B in 2025, about 10% a year.
Running the business leaves about 15¢ of each sales dollar as operating profit, about the same as 16¢ in 2020.
After paying for its upkeep and new investment, it had $602.5M of cash to spare in the 12 months to Sep 2026.
What does management say it's aiming for?
Align says it creates digital technology and experiences to help people move forward in life through better smiles.
“We create digital technology and experiences to help people move forward in life.”
Who is responsible for the plan?
- Joseph M. HoganPresident and Chief Executive Officer
He leads Align Technology through its CEO transition, scheduled for December 31, 2026. Align sells Invisalign clear aligners, iTero scanners and services, and exocad dental software.
- Jitse MarréeExecutive Vice President, Global Operations
He oversees global aligner fabrication, direct fabrication platform operations, and iTero operations. Those operations support Align's Invisalign clear aligners and iTero scanners, which the company sells to dental professionals.
- Srini KazaExecutive Vice President, Research & Development
He leads Align's global product research and development group. His team's materials and product technologies are used in the Invisalign system, part of Align's clear aligner business.
Roles checked November 6, 2026.
What management says it is working on now:
Expand internationally
Management aims to make its products available in more markets and build local operations to support customers and growth.
Align Technology 2025 Form 10-KGrow general dentist use
The company is training and equipping general dentists to identify suitable patients, provide treatment, and monitor progress.
Align Technology 2025 Form 10-KIncrease patient demand
Management is investing in consumer awareness and tools that connect people with Invisalign-trained doctors.
Align Technology 2025 Form 10-KIncrease orthodontist use
The company is expanding the range and predictability of Invisalign treatments, including options for teens and growing patients.
Align Technology 2025 Form 10-KAdvance digital tools and manufacturing
Management says it is investing in AI, digital workflows, and direct 3D fabrication to improve treatment planning, operating efficiency, and customer experience.
Align Technology Announces Second Quarter 2026 Financial Results
- Worldwide revenue growth, Fiscal 2026
- 3% to 4%
- Align Technology Announces Second Quarter 2026 Financial Results
- Clear Aligner volume growth, Fiscal 2026
- Approximately 6%
- Align Technology Announces Second Quarter 2026 Financial Results
- Systems and Services revenue growth, Fiscal 2026
- Down 6% to 8%
- Align Technology Announces Second Quarter 2026 Financial Results
- Non-GAAP operating margin improvement, Fiscal 2026
- Approximately 100 basis points year over year
- Align Technology Announces Second Quarter 2026 Financial Results
- Operating margin improvement, Fiscal 2027
- At least approximately 100 basis points year over year
- Align Technology Announces Second Quarter 2026 Financial Results
- iTero scanner shipment growth, Fiscal 2026
- Double digits year over year
- Align Technology Announces Second Quarter 2026 Financial Results
What's changing right now?
Growth is slowing. In Q3 2026 it sold 2% more than a year earlier. The year before, quarters averaged 4%.
Its operating margin is wider than a year ago: 17¢ per sales dollar, against 10¢.
Since Oct 2026 the share price has risen 8%, from $153.71 to $165.98.
Recently
October 28, 2026
Non-GAAP operating margin, full fiscal year changed to 23.7%
Align Q3 2026 earnings releaseOctober 28, 2026
Clear aligner case shipments, quarterly changed to 690.6 thousand cases
Align Q3 2026 earnings releaseDecember 31, 2025
Clear Aligner Blended ASP changed to $1.2K
Align Technology 2025 Form 10-K
Coming up
Effective September 7, 2026
UK VAT applies to applicable aligners and retainers
Following a UK tribunal decision, Align expects invoices for applicable Invisalign aligners and Vivera retainers to include 20% VAT. The company says list prices will remain unchanged and it intends to appeal.
Align Technology Announces Second Quarter 2026 Financial ResultsPilot releases expected in 2026
Directly fabricated devices
Align expects limited releases of additional devices, including retainers and certain prefabricated attachments, using direct 3D printing.
Align Technology 2025 Form 10-KTiming not stated
UK VAT appeal
Align says it intends to appeal the ruling that clear aligners do not qualify as VAT-exempt dental prostheses; the result remains uncertain.
Align Technology Announces Second Quarter 2026 Financial Results
Our own estimate moved too: the base case went from $73.22 to $76.29 a share between our last two valuations. The biggest reason: Non-GAAP operating margin, full fiscal year moved from an unreported prior value to 23.7%, as reported in Align Q3 2026 earnings release.
What could go wrong?
No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.
Competition and changing treatment preferences
Align competes with braces, other clear aligners, lower-priced scanners, and new digital tools. If patients or dental professionals prefer alternatives, demand or prices for its products could fall.
From the company's own filingsWould hit how fast sales growAlign Technology 2025 Form 10-K
Consumer spending and dental demand
Align says economic uncertainty, inflation, interest rates, and lower consumer confidence can lead people to delay elective dental treatment or choose less costly options, reducing demand.
From the company's own filingsWould hit how fast sales growAlign Technology 2025 Form 10-K
Pricing and product mix
Discounts, lower-priced products, and shifts in the mix of countries and customers can reduce average selling prices. In 2025, lower prices and higher discounts partly offset growth in aligner volume.
From the company's own filingsWould hit how fast sales growAlign Technology 2025 Form 10-K
Suppliers and manufacturing interruptions
Align depends on single or sole suppliers for some key equipment and materials, including resin used for aligners. A supply problem, production interruption, or quality issue could delay manufacturing and delivery.
From the company's own filingsWould hit how much of each sale it keepsAlign Technology 2025 Form 10-K
Tariffs, currencies, and geopolitical events
Trade restrictions or conflict could raise costs, interrupt supply, or reduce demand. Currency movements can also affect reported revenue and expenses because Align operates internationally.
From the company's own filingsWould hit how much of each sale it keepsAlign Technology 2025 Form 10-K
Product development and regulatory approvals
New products must meet customer needs, be manufactured reliably, and receive required regulatory clearances. Delays or weak adoption could limit revenue and leave development costs unrecovered.
From the company's own filingsWould hit how fast sales growAlign Technology 2025 Form 10-K
Q4'26 aligner volume is guided only to low single-digit growth, and total revenue to $1.00-1.02B, against $1.048B in Q4'25.
From our researchWould hit how fast sales growAlign Q3 2026 earnings release
Align continues to invest in manufacturing footprint changes, such as the Juarez facility held for sale, and in new technology like direct 3D-printed aligners.
From our researchWould hit how much it has to reinvestAlign FY2025 10-K
Is it a good business?
From 2016 to 2025 it earned between 10% and 55% on its shareholders' equity, a median of 20%.
Over 10 years its operating margin ranged from 14¢ to 25¢ per sales dollar, a median of 20¢. Gross margin ran from 67¢ to 76¢.
It bought back shares: the count fell 1.9% in a year, so each remaining share owns a slightly bigger slice.
What might it be worth?
Net debt is excluded: The last balance sheet with both cash and debt is too old for this valuation. The per-share value may change when resolved. Last published debt: $56.1M as of 2019-03-31.
The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .
Today a share costs $165.98. Our put its value between $49.13 and $111.57, with $76.29 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .
Bear case, $49.13
Align's sales have been almost flat for four years, and this scenario assumes that continues: more aligner cases but lower prices, a shrinking scanner business, and profits that barely improve.
Base case, $76.29
This scenario assumes Align's nearly flat sales of the past few years slowly pick back up to low single-digit growth as more people choose clear aligners, while recent cost cutting lifts profits somewhat.
Bull case, $111.57
This scenario assumes the steady rise in aligner cases, which hit records in the last year, finally turns into faster sales growth, and that Align's cost cutting brings profits back toward the higher levels it earned before 2022.
Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.
Why the gap?
The price expects far more than we do.Price above value: 118%
For Align Technology to be worth today's $165.98, sales would need to grow about 22.8% a year. We assume 3.0%. Over the last 5 years, sales grew 2.1% a year.
Or, if sales grow 3.0% as we assume, the price works with a profit margin of 43.5% (we assume 20.0%).
Keep in mind: investors are likely paying for things this model leaves out, such as new businesses or many more years of fast growth.
Do you think sales can grow 22.8% a year?
Try your own numbersWe're moderately sure of this range: it scores 65 out of 100 on our checks. The weakest point is terminal-value dependency.
Test the assumptions
Our base value of $76.29 rests on three assumptions. Change any of them to see how the value per share responds.
- Revenue growth, 5-year average3.0%
- Operating margin20.0%
- Long-term growth rate2.5%
This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.
Base estimate
$76.29 -54.0%


